Michael LuBrant, PhD
Michael LuBrant, PhD, remembers watching his grandfather’s body degenerate as a result of an illness at the end of his life.
Jacquetta Blacker, MD, MA, joined the Psychiatry & Behavioral Sciences Department on June 15, 2020, as an Assistant Professor. Before coming to the U, Blacker spent several years working for the Mayo Clinic and Mayo Clinic Health System in Rochester and Austin, MN, as an assistant professor in psychiatry and a senior associate consultant. Blacker is board certified in both adult and child and adolescent psychiatry and will see child psychiatry patients in the inpatient service on the West Bank of the U of M.
A summary of four new initiatives from SCI Faculty: Bruce Walcheck, Mark Osborn, Walter Low and Mei Bigliardi-Qi.
The Department of Pediatrics will graduate its first class of residents from the International Immigrant Medical Graduate Track (IIMG), which offers an additional residency spot to internationally-trained medical graduates who have immigrated to Minnes
The Department of Pediatrics will graduate its first class of residents from the International Immigrant Medical Graduate Track (IIMG), which offers an additional residency spot to internationally-trained medical graduates who have immigrated to Minnesota.
Drs. Alexandra Zachwieja, Kendra Nordgren, and Cathy McCarty on the Medical School’s Duluth campus are leading the way to develop a virtual course addressing the social determinants of health during COVID-19.
Claudia Cohn, MD, PhD, and Jed Gorlin, MD, discuss the use of convalescent plasma in treating COVID-19 and how to donate if someone has recovered from the virus.
Nic Rider, PhD, and Stephanie Terezakis, MD, are co-principal investigators on a new grant from the Radiation Oncology Institute focused on health disparities in cancer care plaguing the LGBTQ population.
Alessandro Bartolomucci, PhD, recently helped publish a review in Science focused on key themes, emerging parallels and insights of social adversity among humans and other animals.
Hossein Nazari, MD, in the Department of Ophthalmology and Visual Neurosciences, leads a team testing whether or not COVID-19 can be diagnosed with tears. If proven, their discovery may lead to a faster, safer and less painful way to test for the virus.